Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. R. Vickery
Rabacfosadine for Relapsed Canine B-Cell Lymphoma: Efficacy and Adverse Event Profiles of 2 Different Doses
Veterinary and Comparative Oncology
Veterinary
Related publications
Concurrent Use of Rabacfosadine and L-Asparaginase for Relapsed or Refractory Multicentric Lymphoma in Dogs
Journal of Veterinary Internal Medicine
Medicine
Veterinary
Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
PLoS ONE
Multidisciplinary
Development and Characterization of 5 Canine B-Cell Lymphoma Cell Lines
Leukemia Research
Cancer Research
Oncology
Hematology
Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase 2 Checkmate 436 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ibrutinib + Chemoimmunotherapy (Cit) for Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma (B-Nhl) in Children (Sparkle Trial): Initial Safety, Pk, and Efficacy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bianca: A Phase 2 Study of the Safety and Efficacy of Tisagenlecleucel in Pediatric Patients With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase 2 Study of Parsaclisib (Incb050465) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl) (Citadel-202)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma
Current Oncology
Oncology
